The largest database of trusted experimental protocols

10 protocols using 454 gs junior platform

1

Soil Metagenomic DNA Extraction and Amplicon Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each sample, genomic DNA was extracted from 500 mg of soil using the FastDNATM SPIN kit for soil (MP Biomedicals, USA) following the manufacturer’s instructions. For fungi, the nuclear ribosomal internal transcribed spacer (ITS) region was amplified using ITS1F and ITS4 primers [30 (link)], while for bacteria, the 16S ribosomal DNA (16S) region was amplified using 27F [31 (link)] and 518R primers [32 ]. Amplicon libraries were prepared using primers with a 454 pyrosequencing adaptor and multiple identifier (MID) tag. The PCR program was as follows: 5 min at 94°C; 35 cycles of 30 s at 94°C, 30 s at 55°C, and 40 s at 72°C; and a final extension step of 5 min at 72°C. PCR products were confirmed using gel electrophoresis and purified using the HighPureTM PCR Product Purification Kit (Roche, Germany). Individual PCR products were quantified using a NanoDrop spectrophotometer (Thermo, USA) and separately pooled for bacteria and fungi. Pyrosequencing was performed with a 454 GS Junior platform (Roche, USA) at ChunLab (Seoul, Korea). DNA was sequenced only in the reverse direction, and data were deposited in the NCBI Sequence Read Archive (SRP046049).
+ Open protocol
+ Expand
2

Methylation Analysis of Pluripotency Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deep bisulfite sequencing was performed on the 454 GS junior platform (Roche) as described previously26 (link). Data analysis was done using the Amplikyzer software27 and results are depicted as methylation heatmaps showing single CpG sites in columns and single reads in rows. The percentage of overall methylation is given in Supplementary Table S6. Amplicon-specific tagged primer sequences are given in Supplementary Table S8, as well as an example for a MID-primer pair. For the Epi-Pluri-Score analysis, pyrosequencing of three CpGs of interest (cg 23737055 in ANKRD46, cg22247240 in VRTN, cg13083810 in POU5F1) was performed and analyzed as described by Lenz et al.13 (link). The Epi-Pluri-Score is calculated as the difference of β-value(ANKRD46) minus β-value(VRTN). A positive value is indicative of pluripotent cells, a negative value of differentiated cells. The Epi-Pluri-Score is plotted against the β-value measured for POU5F1. In the plot, reference sets of 265 pluripotent and 1,951 somatic cells are indicated as clouds. Primer sequences are listed in Supplementary Table S8.
+ Open protocol
+ Expand
3

Genome Resequencing of Evolved Microbes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genomes of the ancestor R0 and the evolved cell population R7 were resequenced using a next-generation sequencer (Junior, Roche). Genomic DNA was purified with a Wizard Genomic DNA Purification kit (Promega) and fragmented using a DNA shearing system (Covaris), according to the manufacturer’s instructions. Whole-genome shotgun sequencing by the 454 GS Junior platform (Roche) was performed according to the manufacturer’s instructions. The sequence reads were assembled using Newbler 2.7 and aligned using the GS Reference Mapper software (ver. 2.6; Roche). Approximately 99% of the reads in each dataset (DRA003743, DDBJ) were uniquely mapped to the MDS42 genome (AP012306, DDBJ). The mutations were analyzed using the GS Reference Mapper software. The candidate mutations were further determined by Sanger methods of the genome samples subjected to a resequencing analysis using a genetic analyzer (ABI PRISM 3100, Applied Biosystems). Sequencing was performed to both the purified genomes and the cell pellets of these populations. In addition, the cell populations (R0–R7) acquired in the experiments of growth curves were repeatedly sequenced for further verification.
+ Open protocol
+ Expand
4

CDH1 Mutation Screening through NGS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Somatic mutations were searched in the promoter region (865 bp) and the 16 exons of the CDH1 gene, including splice sites and adjacent intronic regions. The sequencing reaction was performed through next generation sequencing (NGS) with the Roche 454/GS Junior platform (details in the Additional file 1). The reads were aligned to the reference sequence GRCh38-Chr16 using the BWA-MEM algorithm [7 (link)]. All the variants considered were represented in more than 50 reads and had a value > 100 on the Phred quality score.
The variants were corroborated through capillary sequencing with the Abi Prism 310 Genomic Sequencer, using the BigDye™ Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific Inc.©). Bioinformatics analysis used to characterize the identified variants included three tools: PROMO v.3.0.2 [8 (link), 9 (link)], Human Splicing Finder v.3.0 (HSF) [10 (link)] and Translate ExPASy [11 (link)].
+ Open protocol
+ Expand
5

Targeted NGS for Leukemia Mutation Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
NGS, including data analysis was performed for 30 leukemia-associated target genes on the 454 GS Junior platform with 454 GS Junior Titanium chemistry for amplicon sequencing (Roche Diagnostics, Basel, Switzerland) as previously described. 13, 14 In total, 231 amplicons were prepared for each sample and processed in a single NGS run. Mutations with a frequency >15% were confirmed using Sanger Sequencing with standard techniques on an ABI 3500 Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA, USA) as described previously. 14 DNA-sequencing raw data is available on reasonable request.
+ Open protocol
+ Expand
6

454 Pyrosequencing of Amplified DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amplified PCR products were pooled, and subsequently, a second PCR was performed with primers (Table S2, http://links.lww.com/QAI/B13) containing adaptors for 454 pyrosequencing and a multiplex identifier (MID) sequence to identify each sample (for details on MID sequences, see Table S3, http://links.lww.com/QAI/B13). PCR products were then purified using AMPure PCR purification beads (Beckman Coulter, California, CA) and quantified using Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen, California, CA). In addition, an Agilent 2100 bioanalyzer (Agilent Life Science, California, CA) was used to verify the quality of amplicons. After quality controls, PCR amplicons were clonally amplified on capture beads in water-in-oil emulsion microreactors and sequenced in both forward and reverse directions on the Roche 454 GS-Junior platform (Roche, Switzerland) according to the manufacturer's instructions.
+ Open protocol
+ Expand
7

Amplification and sequencing of HBV genome

Check if the same lab product or an alternative is used in the 5 most similar protocols
A region of the HBV genome (1653–1959 from EcoR1 restriction site) was amplified using a slight modification of a previously described method [18] . Primers 1606 (+) and 1974 (−) were used for the first round PCR, and 1653 (+) and 1959 (−) for the second round PCR. The first round PCR was followed by gel-purification using Zymoclean Gel DNA Recovery Kit (Zymo Research Corp, Irvine, CA, USA). For the second round PCR, modified primers, which were ligated to adaptors and tags, were used (Table 1). Following second round PCR, the amplicons were gel-purified and subjected to UDPS in the forward direction on the Roche 454 GS Junior platform (454 Life Sciences, Roche Company, Switzerland), which provided reads covering the region of interest (coordinates 1653–1959). The UDPS sequencing data has been submitted to the GenBank SRA database, as BioProject accession: PRJNA239442 and the following are the BioSample accessions: SAMN02664575, SAMN02664576, SAMN02664577, SAMN02664578.
+ Open protocol
+ Expand
8

Profiling Bacterial Diversity via 16S rRNA Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The first two variable regions (V1 and V2) of the small subunit rRNA gene were amplified using universal eubacterial primers. The forward primer 27F (5’-AGAGTTTGATCMTGGCTCAG-3’) and the reverse primer 355R (5’-GCTGCCTCCCGAGGAGT-3’) [56 (link), 57 (link)] were complemented with 454 adapters and sample specific ten-nucleotide barcodes (S4 Table) to allow multiple samples to be analyzed in parallel on a single 454 picotiter plate. The pooled DNA was amplified with PCR (Taq DNA Polymerase 2x Master Mix Red, Biomol, GmbH, Germany) under the following running conditions: initial denaturation at 95°C for 5 min, 35 cycles of 1 min at 95°C, 45s at 55°C, 1 min at 72°C, and a final elongation step for 7 min at 72°C. PCR products were confirmed using 1.5% agarose gel electrophoresis and were subsequently isolated from the gel and purified using Gel/PCR DNA Fragments Extraction Kit (Geneaid, Geneaid Biotech Ltd., Taiwan). The mixed pool of PCR products was sequenced at Genomics BioSci & Tech Co. in Taiwan, using the Roche/454 GS Junior platform (Branford, CT, USA). Considering the relatively low reads number of 454 GS Junior platform (about 70,000 amplicons per run), six samples were split into two runs for sequencing.
+ Open protocol
+ Expand
9

Fecal DNA Extraction and 16S rRNA Amplification

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from fecal samples using the QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany) following the manufacturer’s protocol. Amplification of genomic DNA was performed using barcoded primers that targeted the V2 to V3 regions of the bacterial 16S rRNA gene. Amplification, sequencing, and basic analysis were performed by using a GS Junior 454 platform according to the manufacturer’s protocols using a Titanium chemistry apparatus (Roche Applied Science, Indianapolis, IN, United States). For further details, see Moreno-Indias et al. (2015) (link).
+ Open protocol
+ Expand
10

Genetic Profiling of Hematological Malignancies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deletions at the 11q22-q23 (ATM), 17p13 (TP53), 13q14 loci and trisomy of chromosome 12 were detected by FISH by using locus-specific probes (Abott Vysis Inc., Des Plaines, IL, USA or MetaSystems, Altlussheim, Germany). TP53 (ex4-10) mutational analysis was performed by next generation sequencing using the GS Junior 454 platform (Roche, Basel, Switzerland)32 (link) or by Sanger sequencing using standard conditions as described previously.5 (link)ATM (ex4-65) was analyzed by either Sanger sequencing and ATM functional analysis assessing irradiation induced phosphorylation of ATM targets or by resequencing microarray and direct sequencing as described previously.1 (link), 11 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!